Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Inex Pharmaceuticals Corporation

Below is an extended Inex Pharmaceuticals Corporation research listing. Click here to return to the Inex Pharmaceuticals Corporation main Biocorporate entry.

Recent Publications by Inex Pharmaceuticals Corporation:

Methods for the preparation of protein-oligonucleotide-lipid constructs.
A mixture of ionizable cationic lipids, steric barrier lipids, and...
13th July, 2006
Inex Pharmaceuticals Corporation, 100-8900 Glenlyon Parkway, Burnaby, BC, Bioconjug Chem. 2006 Mar-Apr;17(2):451-8.
DOI Direct Link
Micelles as intermediates in the preparation of protein-liposome conjugates.
A method for preparing protein-liposome conjugates based on micelles as...
13th July, 2006
Inex Pharmaceuticals Corporation, 100-8900 Glenlyon Parkway, Burnaby, BC, Bioconjug Chem. 2006 Mar-Apr;17(2):438-50.
DOI Direct Link
Reliability of preparation procedure for sphingosomal vincristine.
PURPOSE: The reliability of the preparation procedure for sphingosomal...
31st December, 2005
Inex Pharmaceuticals Corporation, Burnaby, British Columbia, Canada. Am J Health Syst Pharm. 2005 Aug 1;62(15):1606-12.
DOI Direct Link
Optimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activity.
Vinorelbine (VRL) is a particularly lipophilic member of the vinca...
13th August, 2005
Inex Pharmaceuticals Corporation, 200-8900 Glenlyon Parkway, Glenlyon J Pharm Sci. 2005 May;94(5):1024-38.
DOI Direct Link
Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic Acid.
Polyethylene glycol (PEG) is used widely in the pharmaceutical industry to...
6th April, 2005
Inex Pharmaceuticals Corporation, 100-8900 Glenlyon Parkway, Burnaby, BC, J Pharmacol Exp Ther. 2005 Mar;312(3):1020-6. Epub 2004 Nov 3.
DOI Direct Link
Epicutaneous application of CpG oligodeoxynucleotides with peptide or protein antigen promotes the generation of CTL.
Immunostimulatory oligodeoxynucleotides (ODN) are effective adjuvants in...
26th June, 2004
Inex Pharmaceuticals Corporation, Burnaby, British Columbia, Canada. J Invest Dermatol. 2004 Apr;122(4):1042-9.
DOI Direct Link
A literature review of single agent treatment of multiply relapsed aggressive non-Hodgkin's lymphoma.
To analyze the available literature describing the treatment of relapsed...
26th November, 2002
Inex Pharmaceuticals Corporation, Burnaby, BC, Canada. Leuk Lymphoma. 2002 May;43(5):975-82.
Liposomal encapsulation of topotecan enhances anticancer efficacy in murine and human xenograft models.
Topotecan was encapsulated in sphingomyelin/cholesterol liposomes using an...
19th August, 2000
Inex Pharmaceuticals Corporation, Burnaby, British Columbia, Canada. Cancer Res. 2000 Jul 1;60(13):3389-93.

«Inex Pharmaceuticals Corporation

This page contained an extended Inex Pharmaceuticals Corporation research listing. Click here to return to the Inex Pharmaceuticals Corporation main Biocorporate entry.


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.